Fast track research approval “here to stay,” says regulatorBMJ 2021; 372 doi: https://doi.org/10.1136/bmj.n705 (Published 12 March 2021) Cite this as: BMJ 2021;372:n705
- Rebecca Coombes
- The BMJ
The regulator of UK research says it wants to sustain “in peacetime” the fast track methods it developed for reviewing research during the covid-19 pandemic.
At the height of the pandemic, the Health Research Authority (HRA) cut around 90% off its research approval timeline. Speaking this week, Juliet Tizzard, director of policy and partnership at the regulator, told how around 700 covid-19 studies were reviewed in total over the past year, half of these within 36 hours and some within 24 hours.
“We had to prioritise the urgent stuff. We provided a fast track review service, prioritising the urgent public health studies identified by the chief medical officer and delivered by the National Institute for Health Research …